Stoke Therapeutics at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Stoke Therapeutics at AAPS 2026 PharmSci 360 in New Orleans: 1 presentation (1 poster).

OrganizationAAPS 2026 PharmSci 360 Attendance
Biotech
Biotech developing antisense oligonucleotide medicines that restore protein expression in severe genetic diseases such as Dravet syndrome.
Poster
Tue Oct 27
12:30pm–1:30pm
Development and Qualification of Hybridization Enzyme Linked Immunosorbent Assays (HELISA) for Quantitation of STK-002, an Antisense Oligonucleotide, in Rabbit Ocular Tissues
Solution Center · Poster T1230-05-27
Bioanalytics - Biomolecular

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Stoke Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction